Evidence map›Paper›PMID 25651514›Full record

ArticleAngewandte Chemie (International ed. in English)2015

Selective and potent proteomimetic inhibitors of intracellular protein-protein interactions.

Anna Barnard, Kérya Long, Heather L Martin, Jennifer A Miles, Thomas A Edwards, Darren C Tomlinson, Andrew Macdonald, Andrew J Wilson

Abstract read
In one paragraph

Article in Angewandte Chemie (International ed. in English), 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

34 citing papers in PubMed.

  1. RSC chemical biology · 2026
    Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Aromatic oligoesters as novel helix mimetic scaffolds.Bioorganic & medicinal chemistry · 2023
    Article
  7. Sulfono-γ-AApeptides as Protein Helical Domain Mimetics to Manipulate the Angiogenesis.Chembiochem : a European journal of chemical biology · 2022
    Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Selective Affimers Recognise the BCL-2 Family Proteins BCL-xChembiochem : a European journal of chemical biology · 2021
    Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Inhibition of β-catenin/B cell lymphoma 9 protein-protein interaction using α-helix-mimicking sulfono-γ-AApeptide inhibitors.Proceedings of the National Academy of Sciences of the United States of America · 2019
    Article
  19. Article
  20. Chemical science · 2018
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Anna BarnardSchool of Chemistry, University of Leeds, Woodhouse Lane, Leeds LS2 9JT (UK); Astbury Centre For Structural Molecular Biology, University of Leeds, Woodhouse Lane, Leeds LS2 9JT (UK).
Kérya Long
Heather L Martin
Jennifer A Miles
Thomas A Edwards
Darren C Tomlinson
Andrew Macdonald
Andrew J Wilson

Funding

Medical Research Council MR/K012665/1Wellcome Trust 104920/Z/14/Z
6 · The paper itself

Abstract

Inhibition of protein-protein interactions (PPIs) represents a major challenge in chemical biology and drug discovery. α-Helix mediated PPIs may be amenable to modulation using generic chemotypes, termed "proteomimetics", which can be assembled in a modular manner to reproduce the vectoral presentation of key side chains found on a helical motif from one partner within the PPI. In this work, it is demonstrated that by using a library of N-alkylated aromatic oligoamide helix mimetics, potent helix mimetics which reproduce their biophysical binding selectivity in a cellular context can be identified.

Indexed as

Molecular MimicryCell Line, TumorHumansProteinsProteinsapoptosisfoldamershelical structurespeptidomimeticsprotein-protein interactions

Identifiers

PMID25651514
PMCPMC4506525

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.